AEON Biopharma, Inc. (AEON) — Cash Flow Quality Index
AEON Biopharma, Inc. (AEON) has a Cash Flow Quality Index of -0.87x as of March 2025. Operating cash flow of $-7.91 Million is below net income of $9.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore AEON long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
AEON Biopharma, Inc. Cash Flow Quality Index (2019–2024)
Historical Cash Flow Quality Index for AEON Biopharma, Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See AEON Biopharma, Inc. book value and equity for net asset value and shareholders' equity analysis.
Annual Cash Flow Quality Index for AEON Biopharma, Inc. (2019–2024)
Year-by-year earnings quality comparison for AEON Biopharma, Inc.. For live market cap and the full company financial profile, see AEON Biopharma, Inc. market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.48x | $-20.29 Million | $42.01 Million | ▼ -73.2% |
| 2019 | -0.28x | $-44.73 Million | $160.31 Million | — |